Press releases & In the Press

• 

  French firms partner to provide pet cancer drug services

• 

  ImaBiotech boosts its strategic partnerships

• 

  PR: Metabrain Research and ImaBiotech initiate a strategic partnership to offer cutting-edge preclinical research services in metabolic disorders.

• 

  PR: OCR and ImaBiotech initiate a strategic partnership to provide in situ drug efficacy and target exposure services in Pets with naturally occurring tumors

• 

  Press: ImaBiotech poursuit son développement sur le Parc Eurasanté